Navigation Menu Icon

Heart Valve Voice completes Third Annual Awareness Raising Cycle Ride from London to the EuroPCR Conference in Paris

With the success of the 2018 cycle ride, the team from Heart Valve Voice wake this morning having completed their third awareness raising cycle ride to EuroPCR. The cycle team was made up of HVV Chief Executive Wil Woan and 23 clinicians and patients. The journey began in London on 21 May and will finish with a ride up to the main stage at the EuroPCR Conference in Paris.

“We are so proud of the team, they have worked very much like a heat team. They have supported each other and worked tirelessly to raise awareness of valve disease through their cycling,” said Wil Woan, Heart Valve Voice CEO. “What’s even more exciting is that we had more patients involved this year which helps to strengthen our message that with timely treatment many patients with valve disease can regain an improved quality of life and accomplish things they never dreamed of before!”

“It is so important that the general public, particularly those over the age of 65 are aware of the symptoms involved with valvular heart disease and that they are having their hearts listened to and, if needed, being referred for an echocardiogram so that they can be diagnosed/treated/managed in a timely way. With the diagnosis confirmed on echocardiography the clinician can ensure patients receive the right treatment at the right time, and therefore improving the optimal outcome for patients.”

The ride came to an end as the cyclists made their way up on the main stage at the EuroPCR conference which is the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and a world-leading course in Interventional Cardiovascular Medicine that hosts cardiac experts from all over the globe. The ideal place to finish such an amazing feat for these wonderful patients and clinicians.

Learn more here

Heart Valve Voice - Overview

Upcoming Events

Heart valve disease is caused by either wear, disease or damage of one or more of the heart’s valves, affecting the flow of blood through the heart.